Akademik Veri Yönetim Sistemi
II. INTERNATIONAL CANCER DAYS, Sivas, Türkiye, 16 - 18 Eylül 2021, ss.216-221
In our study, between 2011 and 2020, the data of 460 patients (18-89 years old) who applied to different
clinics of Sivas Cumhuriyet University Application and Research Hospital, whose "anti-HCV and HCV-RNA
positive and HCV genotype values" were retrospectively investigated. Also the HCV genotype frequency, the
age, gender and genotype distribution of the patients who developed HCC were determined. The mean age of
male patients was found to be significantly lower than female patients. The frequency of HCV genotype 1b
was found to be quite high. This result is similar to the HCV genotype 1b rates previously reported from our
country. In addition, it has been observed that genotype 1b is dominant in a limited number of cancer types,
especially HCC. Although the number of data in our study is limited, the incidence of HCC was higher in male
than in female. Also anti-HCV and HCV RNA positive patients were diagnosed with HCC within a minimum
of 2 years, a maximum of 10 years, and a mean of 5.5 years.